• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA expands J&J's psoriasis drug for inflammatory bowel disease

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 11, 2024 at 11:12: PM
via The U.S. Food and Drug Administration has allowed the expanded use of Johnson & Johnson's (JNJ.N) drug, Tremfya, to treat adults with a type of chronic inflammatory bowel disease, the company said on Wednesday.

article source
 

<



Similar threads

cafead
FDA expands use of controversial J&amp;J antidepressant
Replies
0
Views
163
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across...
Replies
0
Views
141
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA expands Qulipta indication to include chronic migraine prevention
Replies
0
Views
229
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA expands use of Regeneron&#039;s HoFH drug Evkeeza to kids 5 and up
Replies
0
Views
136
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Omnibus spending bill expands FDA’s unannounced foreign inspections pilot
Replies
0
Views
203
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote